Stay updated on AK119 & AK104 Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AK119 & AK104 Combo in Solid Tumors Clinical Trial page.

Latest updates to the AK119 & AK104 Combo in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has been updated to reflect a terminated status and an adjustment in the development strategy, with a new date of February 19, 2025.SummaryDifference9%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the intervention type to 'Verified 2022-12 by Akeso' and noted that the last known status is 'Recruiting', while the previous revision 'v2.13.3' has been removed.SummaryDifference2%
- Check99 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to AK119 & AK104 Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK119 & AK104 Combo in Solid Tumors Clinical Trial page.